Cytokinetics Inc (CYTK)

EBITDA Margin

-1158.11%

TTM · Period ending:

CYTK logo

CYTK EBITDA Margin

Latest reported-1158.11%
CYTK TTM EBITDA Margin (-449.61% → -1158.11%)
High-resolution chart · PNG

CYTK ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Cytokinetics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-1,158.1116%
-694.1218%
-796.5754%
-740.9272%
-588.8043%
-2,672.609%
-2,671.2298%
-14,971.6372%
-14,667.2942%
-12,166.178%
-6,052.4436%
-5,907.9335%
-4,748.6736%
-375.0788%
-350.2611%
-157.3213%
-117.2666%
-342.4925%
-260.8423%
-910.2042%
-210.9323%
-168.0825%
-158.6731%
-141.3509%
-562.3227%
-449.4219%
-346.2818%
-295.2115%
-239.6614%
-235.2999%
-264.0138%
-442.2826%
-615.7155%
-767.2236%
-814.5946%
-151.1478%
-9.038%
4.2285%
14.03%
3.1881%
-126.036%
-121.9593%
-128.4737%
-47.6893%
-39.2129%
-33.1135%
-30.3877%
-32.9127%
-51.4523%
-78.3024%
-109.1784%
-605.2222%
-851.3617%
-650.0457%
-527.411%
-653.7182%
-693.379%
-888.4912%
-1,161.45%
-1,059.6269%
-1,440.4654%
-1,730.7947%
-1,840.0621%
-1,965.8%
-587.3226%
34.9671%
35.8279%
37.6401%
31.3539%
-399.6219%
-435.9903%
-467.3857%
-424.2845%
-409.3059%
-393.8996%
-521.5337%
-878.7747%
-1,195.0936%
-1,867.9565%
-1,037.7248%
-696.0524%
-566.6108%
-466.4722%
-468.0231%
-437.5678%
-397.4574%
-261.5608%
-463.254%
-368.0825%
-348.3843%
-449.6082%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.